Diying Shen

4.0k total citations · 1 hit paper
34 papers, 3.0k citations indexed

About

Diying Shen is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Hematology. According to data from OpenAlex, Diying Shen has authored 34 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 9 papers in Oncology and 8 papers in Hematology. Recurrent topics in Diying Shen's work include Acute Lymphoblastic Leukemia research (9 papers), CAR-T cell therapy research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Diying Shen is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), CAR-T cell therapy research (6 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Diying Shen collaborates with scholars based in China, United States and Russia. Diying Shen's co-authors include A.J. Grillo-López, Isabelle Bence‐Bruckler, Peter McLaughlin, M. S. Czuczman, B.K. Dallaire, Christine A. White, Meyer R. Heyman, Brian K. Link, Michael E. Williams and Anthony D. Ho and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Diying Shen

30 papers receiving 2.9k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1998 2.2k citations Peter McLaughlin, A.J. Grillo-López et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diying Shen China	10	1.7k	1.2k	1.2k	1.1k	905	34	3.0k
Isabelle Bence‐Bruckler Canada	18	2.0k 1.2×	1.5k 1.2×	1.4k 1.2×	995 0.9×	853 0.9×	62	3.5k
Meyer R. Heyman United States	14	1.4k 0.8×	1.1k 0.9×	924 0.8×	752 0.7×	699 0.8×	22	2.8k
DG Maloney United States	23	1.3k 0.8×	1.1k 0.9×	882 0.8×	1.4k 1.3×	1.2k 1.3×	37	3.1k
C. Varns United States	9	1.5k 0.9×	986 0.8×	795 0.7×	969 0.9×	572 0.6×	9	2.4k
Robin Joyce United States	26	1.4k 0.8×	1.5k 1.3×	656 0.6×	848 0.8×	1.5k 1.7×	94	4.0k
Charles W. Ross United States	23	1.6k 0.9×	1.0k 0.8×	535 0.5×	995 0.9×	405 0.4×	65	2.7k
Rémy Gressin France	26	1.7k 1.0×	1.2k 1.0×	880 0.8×	279 0.3×	561 0.6×	109	2.5k
Roland Repp Germany	36	1.1k 0.7×	1.4k 1.2×	615 0.5×	1.7k 1.6×	2.2k 2.4×	85	4.3k
Andreas Viardot Germany	28	2.0k 1.1×	3.0k 2.5×	806 0.7×	920 0.9×	1.1k 1.2×	131	4.6k
Roch Houot France	38	1.5k 0.9×	2.7k 2.2×	631 0.5×	462 0.4×	1.9k 2.1×	181	4.3k

Countries citing papers authored by Diying Shen

Since Specialization

Citations

This map shows the geographic impact of Diying Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diying Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diying Shen more than expected).

Fields of papers citing papers by Diying Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diying Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diying Shen. The network helps show where Diying Shen may publish in the future.

Co-authorship network of co-authors of Diying Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Diying Shen. A scholar is included among the top collaborators of Diying Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diying Shen. Diying Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, En‐Min, Yongmin Tang, Chan Liao, et al.. (2025). Multi-courses of blinatumomab combined with reduced dose chemotherapy has been successfully used in chemo-intolerant middle to high-risk pediatric B-ALL patients with invasive fungal disease. Annals of Hematology. 104(6). 3495–3504.

Shen, Diying, Liqun Zhang, Yanru Liu, et al.. (2024). Gamified Adaptive Approach Bias Modification in Individuals With Methamphetamine Use History From Communities in Sichuan: Pilot Randomized Controlled Trial. JMIR Serious Games. 13. e56978–e56978.

Zhang, Jingying, Chun‐Rong Chen, Diying Shen, et al.. (2024). Targeted gene sequencing and transcriptome sequencing reveal characteristics of NUP98 rearrangement in pediatric acute myeloid leukemia. European journal of medical research. 29(1). 448–448. 1 indexed citations

Wang, Di, Zihan Zhang, Heping Shen, et al.. (2024). Comparison of plasma and blood cell samples in metagenomic next-generation sequencing for identification of the causative pathogens of fever. Heliyon. 10(11). e31677–e31677. 2 indexed citations

Shen, Diying, Lixia Liu, Xiaojun Xu, et al.. (2023). Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia. BMC Pediatrics. 23(1). 62–62. 2 indexed citations

Liang, Juan Boo, Hua Song, Jingying Zhang, et al.. (2023). Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL. Nature Communications. 14(1). 7468–7468. 10 indexed citations

Zhang, Jingying, Xiaojun Xu, Lixia Liu, et al.. (2022). Clinical and Genetic Characteristics of IKZF1 Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia. Frontiers in Genetics. 13. 822832–822832. 1 indexed citations

Liao, Chan, Diying Shen, Xiaojun Xu, et al.. (2020). High CD38 expression in childhood T-cell acute lymphoblastic leukemia is not associated with prognosis. Cancer Biomarkers. 27(2). 277–284. 5 indexed citations

Shen, Heping, Diying Shen, Hua Song, et al.. (2020). Clinical assessment of the utility of metagenomic next‐generation sequencing in pediatric patients of hematology department. International Journal of Laboratory Hematology. 43(2). 244–249. 28 indexed citations

10.

Li, Sisi, Diying Shen, Xiaoping Guo, Chan Liao, & Yongmin Tang. (2018). Construction, Expression, and Characterization of a Novel Human–Mouse Chimeric Antibody, Hm3A4: A Potential Therapeutic Agent for B and Myeloid Lineage Leukemias. DNA and Cell Biology. 37(9). 778–785. 2 indexed citations

11.

Zhang, Jingying, et al.. (2017). The targeting effect of Hm2E8b–NCTD–liposomes on B-lineage leukaemia stem cells is associated with the HLF–SLUG axis. Journal of drug targeting. 26(1). 55–65. 6 indexed citations

12.

Yang, Shilong, Xiaojun Xu, Yongmin Tang, et al.. (2016). Associations between inflammatory cytokines and organ damage in pediatric patients with hemophagocytic lymphohistiocytosis. Cytokine. 85. 14–17. 48 indexed citations

13.

Shen, Diying, et al.. (2014). Successful Construction and Massive Expression of a Novel Anti-CD19 Human-Mouse Chimeric Antibody Hm2E8b. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 33(4). 215–220. 2 indexed citations

14.

Shen, Hongqiang, Yongmin Tang, Huamei Li, et al.. (2014). Staging and monitoring of childhood rhabdomyosarcoma with flow cytometry. Oncology Letters. 7(4). 970–976. 5 indexed citations

15.

Mao, Junqing, et al.. (2013). [Thioguanine treatment-related sinusoidal obstruction syndrome in 2 children].. PubMed. 15(9). 788–90. 2 indexed citations

16.

Shen, Diying, et al.. (2009). Mutations in patients with hyperphenylalaninemia in Zhejiang, China. Genes & Genomics. 31(1). 85–88. 1 indexed citations

17.

Grillo-López, A.J., Christine A. White, C. Varns, et al.. (1999). Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma.. PubMed. 26(5 Suppl 14). 66–73. 226 indexed citations

18.

Cai, Shaohui, et al.. (1999). Gene deletion and carrier detection in the family of Becker muscular dystrophy by short tandem repeat sequence polymorphism.. PubMed. 112(3). 242–5. 1 indexed citations

19.

Berinstein, Neil L., A.J. Grillo-López, Christine A. White, et al.. (1998). Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma. Annals of Oncology. 9(9). 995–1001. 444 indexed citations

20.

McLaughlin, Peter, A.J. Grillo-López, Brian K. Link, et al.. (1998). Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.. Journal of Clinical Oncology. 16(8). 2825–2833. 2153 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact